FMR LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$13,527,010
-35.6%
555,524
-10.7%
0.00%0.0%
Q1 2024$21,000,145
-22.9%
621,858
-28.1%
0.00%
-50.0%
Q4 2023$27,253,208
+13.4%
864,358
-8.1%
0.00%0.0%
Q3 2023$24,024,180
-3.3%
940,281
+8.6%
0.00%0.0%
Q2 2023$24,842,616
-37.4%
866,200
-47.7%
0.00%0.0%
Q1 2023$39,713,112
+157.2%
1,656,784
+82.0%
0.00%0.0%
Q4 2022$15,437,713
+9.2%
910,243
-4.6%
0.00%
+100.0%
Q3 2022$14,143,000
-2.4%
954,325
+3.6%
0.00%0.0%
Q2 2022$14,493,000
-41.6%
920,757
-0.0%
0.00%
-50.0%
Q1 2022$24,825,000
-27.1%
920,796
+0.0%
0.00%
-33.3%
Q4 2021$34,069,000
-33.5%
920,524
-14.2%
0.00%
-25.0%
Q3 2021$51,267,000
+107.4%
1,072,977
+46.9%
0.00%
+100.0%
Q2 2021$24,713,000
-18.1%
730,2900.0%0.00%
-33.3%
Q1 2021$30,161,000
-4.8%
730,2900.0%0.00%0.0%
Q4 2020$31,680,000
-4.1%
730,290
-5.2%
0.00%0.0%
Q3 2020$33,033,000
+4.7%
770,000
+14.1%
0.00%0.0%
Q2 2020$31,550,000
+480.4%
675,000
+68.8%
0.00%
+200.0%
Q1 2020$5,436,000
+25.0%
400,0000.0%0.00%
Q4 2019$4,348,000
+5.8%
400,0000.0%0.00%
Q3 2019$4,108,000400,0000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2020
NameSharesValueWeighting ↓
Portolan Capital Management 484,907$11,807,4850.97%
Nikko Asset Management Americas, Inc. 1,563,065$37,966,8490.44%
Diametric Capital, LP 32,765$797,8270.43%
ARK Investment Management 1,964,964$47,846,8710.42%
SummerHaven Investment Management, LLC 23,400$569,7900.38%
Quantedge Capital Pte Ltd 40,800$993,4800.36%
Granahan Investment Management 344,549$8,389,7680.34%
FEDERATED HERMES, INC. 4,694,060$114,300,3610.27%
Belmont Capital, LLC 40,000$974,0000.18%
Woodline Partners LP 754,023$18,360,4600.18%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders